Universal Ibogaine Inc. (IBO.V)

CAD 0.02

(0.0%)

Total Assets Summary of Universal Ibogaine Inc.

Universal Ibogaine Inc.'s latest annual total assets in 2022 was 6.31 Million CAD , up 58.27% from previous year.
Universal Ibogaine Inc.'s latest quarterly total assets in 2023 Q3 was 5.87 Million CAD , down -2.12% from previous quarter.
Universal Ibogaine Inc. reported annual total assets of 3.99 Million CAD in 2021, up 3323.04% from previous year.
Universal Ibogaine Inc. reported annual total assets of 116.61 Thousand CAD in 2020, down -46.31% from previous year.
Universal Ibogaine Inc. reported quarterly total assets of 6 Million CAD for 2023 Q2, down -3.77% from previous quarter.
Universal Ibogaine Inc. reported quarterly total assets of 6.23 Million CAD for 2023 Q1, down -1.27% from previous quarter.

Annual Total Assets Chart of Universal Ibogaine Inc. (2022 - 2017)

Historical Annual Total Assets of Universal Ibogaine Inc. (2022 - 2017)

Year	Total Assets	Total Assets Growth
2022	6.31 Million CAD	58.27%
2021	3.99 Million CAD	3323.04%
2020	116.61 Thousand CAD	-46.31%
2019	217.2 Thousand CAD	-32.26%
2018	320.66 Thousand CAD	-20.94%
2017	405.6 Thousand CAD	0.0%

Year	Total Assets	Total Assets Growth
2023 Q3	5.87 Million CAD	-2.12%
2023 Q2	6 Million CAD	-3.77%
2023 Q1	6.23 Million CAD	-1.27%
2022 Q3	10.36 Million CAD	0.0%
2022 Q1	13.04 Million CAD	155.41%
2022 Q4	6.31 Million CAD	-39.06%
2022 FY	6.31 Million CAD	58.27%
2021 Q1	119.58 Thousand CAD	-25.64%
2021 FY	3.99 Million CAD	3323.04%
2021 Q4	5.1 Million CAD	132.36%
2021 Q3	2.19 Million CAD	2922.73%
2021 Q2	72.74 Thousand CAD	-39.17%
2020 Q2	137.24 Thousand CAD	-23.54%
2020 Q1	179.49 Thousand CAD	-13.37%
2020 FY	116.61 Thousand CAD	-46.31%
2020 Q4	160.82 Thousand CAD	37.91%
2020 Q3	116.61 Thousand CAD	-15.03%
2019 Q3	217.2 Thousand CAD	-9.82%
2019 Q2	240.85 Thousand CAD	-6.58%
2019 Q1	257.8 Thousand CAD	-11.38%
2019 FY	217.2 Thousand CAD	-32.26%
2019 Q4	207.19 Thousand CAD	-4.61%
2018 Q4	290.92 Thousand CAD	-9.27%
2018 FY	320.66 Thousand CAD	-20.94%
2018 Q3	320.66 Thousand CAD	0.0%
2018 Q1	493.06 Thousand CAD	-22.25%
2017 FY	405.6 Thousand CAD	0.0%
2017 Q4	634.18 Thousand CAD	0.0%

Peer Total Assets Comparison of Universal Ibogaine Inc.

Name	Total Assets	Total Assets Difference
Arch Biopartners Inc.	1.17 Million CAD	-439.427%
Covalon Technologies Ltd.	24.9 Million CAD	74.629%
Hemostemix Inc.	313.76 Thousand CAD	-1913.486%
Kane Biotech Inc.	5.68 Million CAD	-11.208%
MedMira Inc.	3.65 Million CAD	-73.0%
Marvel Biosciences Corp.	672.38 Thousand CAD	-839.577%
NervGen Pharma Corp.	13.23 Million CAD	52.27%
XORTX Therapeutics Inc.	7.21 Million CAD	12.378%